0.38
-0.0207(-5.17%)
Currency In USD
| Previous Close | 0.4 |
| Open | 0.41 |
| Day High | 0.41 |
| Day Low | 0.38 |
| 52-Week High | 2.82 |
| 52-Week Low | 0.28 |
| Volume | 1.38M |
| Average Volume | 788,718 |
| Market Cap | 16.89M |
| PE | -0.29 |
| EPS | -1.29 |
| Moving Average 50 Days | 0.46 |
| Moving Average 200 Days | 0.7 |
| Change | -0.02 |
If you invested $1000 in Harvard Bioscience, Inc. (HBIO) 10 years ago, it would be worth $98.78 as of October 19, 2025 at a share price of $0.379. Whereas If you bought $1000 worth of Harvard Bioscience, Inc. (HBIO) shares 5 years ago, it would be worth $117.8 as of October 19, 2025 at a share price of $0.379.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
GlobeNewswire Inc.
Sep 16, 2025 11:00 AM GMT
- Strategic expansion with trusted partner enhances customer reachHOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider of innovative laboratory equi
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
GlobeNewswire Inc.
Sep 09, 2025 11:00 AM GMT
Veteran life sciences industry financing leader appointed as new Board memberHOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced the appointment of Ste
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
GlobeNewswire Inc.
Aug 04, 2025 8:30 PM GMT
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to disc